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Abstract
Background: Hospital wastewater is commonly polluted with high loads of pharmaceutically active compounds,
which pass through wastewater treatment plants (WWTPs) and end up in water bodies, posing ecological and
health risks. White-rot fungal treatments can cope with the elimination of a wide variety of micropollutants while
remaining ecologically and economically attractive. Unfortunately, bacterial contamination has impeded so far a
successful implementation of fungal treatment for real applications.
Results: This work embodied a 91-day long-term robust continuous fungal operation treating real non-sterile
hospital wastewater in an air pulsed fluidized bed bioreactor retaining the biomass. The hydraulic retention time
was 3 days and the ageing of the biomass was avoided through partial periodic biomass renovation resulting in a
cellular retention time of 21 days. Evolution of microbial community and Trametes abundance were evaluated.
Conclusions: The operation was able to maintain an average pharmaceutical load removal of over 70% while
keeping the white-rot fungus active and predominant through the operation.
Keywords: Fungal bioreactor, Pharmaceutical active compounds, Microbial community, Hospital wastewater,
Pretreatment
Background
Pharmaceutically active compounds (PhACs) occurrence
in water bodies remains an issue of environmental con-
cern despite persistent efforts of the scientific and global
community to cope with the problem. PhACs can be
found at relevant concentrations in the environment and
can pose a wide range of risks to the ecosystem and hu-
man health [1–3]. Wastewater treatment plants (WWTPs)
are the primary source of PhACs into the environment,
since they are not designed nor operated to remove these
micropollutants [4]. Hospital wastewater (HWW)
contains higher concentrations of PhACs, which make
hospitals a good target for on-site treatment [5]. Other-
wise, HWW is usually discharged untreated to the sewer
network, thus contributing to the PhACs loads into
WWTP influent [3].
Removing such micropollutants from water streams is
not trivial, although many advances have been achieved
in that direction. While many studies have dealt with the
degradation of single pollutants, real streams have
mixtures of several contaminants, thus a robust process
should be capable of coping with the removal of most
micropollutants. Amongst the biological oxidation
processes, white-rot fungi (WRF) have proved to be
especially well-suited for removing and degrading a wide
range of pharmaceuticals [6, 7]. A versatile enzymatic
system comprising both intracellular (e.g., cytochrome
P450 system) and extracellular enzymes (e.g.,
laccase-mediators system) allows these fungi to trans-
form most of the PhACs, usually very recalcitrant, to
more biodegradable compounds or even achieve
complete mineralization [8, 9]. Therefore, a fungal
system has been regarded as a feasible approach for
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pretreating hospital effluents prior to discharge to the
WWTP, as some pharmaceuticals would be removed
and other transformed into more biodegradable
compounds, suitable for the posterior conventional acti-
vated sludge treatment (CAS) [10]. This approach sug-
gests a single fungal process that can remove most
pharmaceutical load, rather than using a specific treat-
ment for every compound. However, full scale applica-
tions of this technology do not exist at the moment.
Developments in this direction depend on overcoming
several shortcomings, namely: (1) maintaining a stable
activity of the fungal pellets over prolonged periods of
time and (2) preserving good performance in non-sterile
conditions, as sterility would be unviable from the
economic and ecological perspective. On one hand,
removal efficiency can be higher in non-sterile matrices
than in sterile conditions due to the consortium estab-
lished [11]. Additionally, in non-sterile matrices bacteria
could degrade the most biodegradable transformation
products of the xenobiotic parent compounds
transformed by the WRF [12]. On the other hand,
non-sterility reduces the duration of bioreactor oper-
ation due to native microorganisms exerting competitive
pressure in WRF survival. This aspect has been partly
resolved by introducing a pretreatment step that reduces
the initial concentration of microorganisms in the influ-
ent [13]. A partial biomass regeneration strategy could
also help to increase the duration of the bioreactor oper-
ation [14]. In any case, the interactions between the
inoculated fungus and the microbial community existing
in the wastewater and developed during the treatment
seem to be case-dependent and are highly complex. This
fact calls for a thorough study of the microbial commu-
nities developed during a more stable, long-term oper-
ation. Furthermore, identification of native HWW
PhACs degraders could lead to a better understanding of
the process and improvement in the reactor operation.
Some studies have optimized values for pH, temperature,
growth conditions, aeration, pellet size, biomass renovation
and nutrients addition [14–16]. Those previous studies
enabled this long-term operation of a fungal fluidized bed
bioreactor treating real non-sterile wastewater for the first
time. The objectives of the study were to prove the concept
of a long-term fungal treatment of real HWW, evaluating
the bacterial and fungal communities arisen during the
treatment and monitoring the abundance of the inoculated
fungi to assess the removal efficiency for PhACs.
Methods
Reagents, fungus and hospital wastewater
Thiamine hydrochloride was acquired from Merck (Barce-
lona, Spain) and glucose, ammonium chloride and other
chemicals were purchased from Sigma-Aldrich (Barcelona,
Spain). Primers were acquired from Invitrogen (Barcelona,
Spain) and quantitative PCR supermix from Bio-Rad
(Barcelona, Spain). All other chemicals used were of
analytical grade. Coagulant Hyfloc AC50 and floccu-
lant Himoloc DR3000 were kindly provided by Dery-
pol, S.A. (Barcelona, Spain).
T. versicolor (ATCC#42530) was maintained on 2%
malt agar slants at 25 °C until use. Subcultures were
routinely made. A mycelial suspension of T. versicolor
was traditionally obtained as previously described else-
where [14]. After the startup, the mycelial suspension
was obtained with the novel method by homogenization
of pelleted biomass described elsewhere [16].
The HWW was collected from the sewer manifold of
Sant Joan de Déu Hospital (Barcelona, Catalonia) in the
NE of Spain. The physic-chemical characteristics of the
wastewater are summarized in Additional file 1: Table S1.
Medium and pellet growth
Fungal pellets of 2 ± 1mm of diameter were obtained as
previously described by Borràs et al. (2008) [15] by
inoculating 20mL·L− 1 of the mycelial suspension in 2 L
of a defined medium in a sterile glass air-pulsed fluidized
bioreactor. The medium contained, per liter: 7 g glucose,
100 mL macronutrients, 10 mL micronutrients, 2.1 g
NH4Cl and 10 mg thiamine [15]. The pH was controlled
at 4.5 by adding HCl 1M or NaOH 1M, the O2 was
measured and the temperature was maintained at 25 °C;
pH and temperature profiles can be found in Additional
file 1: Figure S1. Air pulses (1 s air pulse every 4 s) pro-
vided 0.8 L·min− 1 pulsed aeration and fluidization to the
reactor.
HWW treatment
Hospital wastewater was pretreated with a coagulation-
flocculation process (38 mg·L− 1 of coagulant and 3.3
mg·L− 1 of flocculant) as described previously [13]. In
order to have a constant influent during all the experi-
ment, the flocculated wastewater was distributed in
bottles and stored at − 20 °C. This methodology will help
the interpretation of the the results.
After the pellet growth, the pellets were retained in
the 2 L reactor, the medium was withdrawn and the
reactor filled with pretreated HWW. The fluidized bed
reactor operated continuously with a hydraulic residence
time (HRT) of 3 days. A partial biomass renovation strat-
egy described by Blánquez et al. (2006) produced a cellu-
lar retention time (CRT) of 21 d [14]. Glucose and
NH4Cl were added to the reactor at consumption rate,
with a carbon-to-nitrogen ratio of 7.5 (mol/mol). Sam-
ples were withdrawn periodically for analysis.
Analysis of pharmaceuticals
Samples from the effluent were removed weekly and an-
alyzed per triplicate following the analytical procedure
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described elsewhere [5]. A list of 74 PhACs were ana-
lysed. This can be seen in Additional file 1: Table S2.
Briefly, 10 mL of sample for raw HWW and 25mL for
treated HWW were pre-concentrated by Solid Phase Ex-
traction as previously described [17]. Elution was done
with 6 mL of pure methanol. The extracts were evapo-
rated under nitrogen stream and reconstituted with 1
mL of methanol-water (10:90 v/v). 10 μL of standard of
internal standard mix at 1 ng·μL− 1 were added for
calibration. Separation was carried out using an
Ultra-Performance liquid chromatography system (Wa-
ters Corp. Milford, MA, USA), equipped with an
Acquity HSS T3 column (50 mm × 2.1 mm i.d. 1.7 μm)
for the compounds analyzed under positive electrospray
ionization and an Acquity BEH C18 column (50 mm ×
2.1 mm i.d., 1.7 μm) for the ones analyzed under negative
electrospray ionization, both from Waters Corporation.
The UPLC was coupled to a 5500 QqLit, triple quadru-
pole–linear ion trap mass spectrometer (5500 QTRAP,
Applied Biosystems, Foster City, CA, USA) with a Turbo
V ion spray source. Two MRM transitions per com-
pound were recorded by using the Scheduled MRM™
algorithm and the data were acquired and processed
using Analyst 2.1 software.
Microbial community analysis
Pelleted biomass samples from the reactor were centri-
fuged at 14.000 rpm and pellets were freeze-dried and
stored at − 80 °C. Liquid samples from the reactor were
filtered through 0.22 μm GV Durapore® membrane filters
(Merck Millipore, USA) and filters were stored at − 80 °
C. Total DNA extraction, PCR amplification and
denaturing gradient gel electrophoresis (DGGE) were
conducted as previously described [17].
Bands from the gel were excised, reamplified and then
sequenced by Macrogen (Madrid, Spain). Sequences
were trimmed and checked for chimeras using Mothur
[18]. Each 16S rRNA sequence was assigned to its clos-
est neighbor according to the Basic Local Alignment
Search Tool (BLAST) results [19]. Representative se-
quences of each band were deposited in GeneBank
under the accession numbers MF682288 to MF682321
and MF683211 to MF683229 for bacteria and fungi,
respectively.
The qPCR assay was performed using a specific primer
set targeting T. versicolor [20] and the following amplifi-
cation protocol: 95 °C for 10 min and 40 cycles of 95 °C
for 15 s and 60 °C for 1 min. Reactions contained 1×
ssoAdvanced Universal SYBR Green Supermix
(Bio-Rad), 0.3 μM of each forward and reverse primers
and 12 ng of sample DNA in a final volume of 20 μL. All
reactions were run in triplicate in a CFX95 Real-Time
System (Bio-Rad) with a resulting amplification
efficiency of 96.5% and R2 value of 0.999. A calibration
curve was prepared using a purified amplicon (302 bp)
from the Internal Transcribed Spacer (ITS) region of T.
versicolor ATCC 42530.
Other analyses
Turbidity was determined as the absorbance at 650 nm
by a UNICAM 8625 UV/VIS spectrometer and the con-
ductivity by a CRISON MicroCM 2100 conductometer.
Chloride, sulfate, nitrate and phosphate anions were
quantified by a Dionex ICS-2000 ionic chromatograph.
The total suspended solids (TSS) were determined
according to the Standard Methods for the Examination
of Water and Wastewater [21]. Ammonia concentration
and chemical oxygen demand (COD) were analyzed by
using commercial kits LCK114 or LCK314, respectively
(Hach Lange, Germany). Glucose concentration was
measured with a YSI 2700 SELECT enzymatic analyzer
(Yellow Spring Instruments). Laccase activity was mea-
sured per duplicate using a modified version of the
method for the determination of manganese peroxidase
where 2,6-dimetoxyphenol (DMP) is oxidized by laccase
in the absence of a cofactor [22]. Activity units per liter
(U·L− 1) are defined as the micromoles per liter of DMP
oxidized per minute. The molar extinction coefficient of
DMP was 24.8 mM− 1·cm− 1 [23].
Statistical analysis
A robust Regression on Order Statistics (ROS) approach
was used for dealing with left-censored data, namely:
below limit of detection (BLD) and below limit of quan-
tification (BLQ) values [24]. When ROS was not pos-










analysis was performed with R: A language and environ-
ment for statistical computing. ROS was performed
using the R package NADA [25].
Results and discussion
Physicochemical characteristics of the wastewater used
are summarized in Additional file 1: Table S1. All values
fell within the range of similar wastewaters, either from
the same hospital or from other hospitals of the same
region [13, 17]. The approximately 75% decrease of both
TSS and COD after flocculation was also reported previ-
ously. The wastewater was taken from a hospital with an
important psychiatric ward; therefore, high levels of psy-
chiatric drugs were detected. Out of 74 compounds ana-
lyzed, 45 were detected and from those, 11 belonged to
the psychiatric drugs group. The PhACs concentration
before and after the coagulation-flocculation pretreat-
ment of the HWW are summarized in Additional file 1:
Table S2. A total concentration of 7 μg·L− 1 psychiatric
drugs was measured, being carbamazepine and its
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transformation products (2-OH-CBZ, acridone, epoxy-
CBZ) and venlafaxine and their transformation products
(TPs) (N-desmethyl-venlafaxine and O-desmethyl-venlafax-
ine) the most abundant ones. The presented psychiatric
pharmaceuticals concentration, around 15.4% of the initial
load was substantially lower than in other psychiatric hospi-
tals [26], but higher than other founded in general hospitals
[27]. As it is common in HWW, the analgesics and
anti-inflammatories family contributed the most to the
overall pharmaceutical load (75% in this study) [12, 28],
with ibuprofen, salicylic acid (a transformation product of
aspirin) and acetaminophen (also known as paracetamol),
in that order, being the most important of the group.
Reactor performance
Reactor performance was evaluated through the moni-
toring of laccase activity and glucose concentration
along the treatment as a measure of fungal activity; since
real-time determination of micropollutant concentration
is not feasible. Laccase activity profile during the oper-
ation is presented in Fig. 1. Two periods could be
observed. The first, before 63th day, where laccase is de-
tected around 30 U·L− 1 in a pseudo steady state. The
second period, after 63th day, extracellular laccase activ-
ity levels remainedinsignificant. Although laccase activity
was detected and glucose concentration was very low,
the reactor gained a pinkish color between days 33 and
37, when reactor biomass was replaced by fresh pellets.
As the initial week of process, the highest peaks of lac-
case were detected. Laccase activity could be linked to
Trametes activity, but the low laccase activity detected at
the end of the treatment could not be linked to the
inactivation of the fungus, as demonstrated previously
[13]. In fact, T. versicolor was maintained throughout the
operation even when laccase could not be detected (dis-
cussed in section Evolution of bacterial and fungal popula-
tions in the bioreactor) thus confirming the
non-correlation between absence of laccase activity and
fungal inactivation. As glucose was added at consumption
rate, glucose concentration remained insignificant during
the treatment.
Pharmaceutical load removal
Time-course profile of concentrations of PhACs is pre-
sented in Fig. 2, organized by families. The initial con-
centration of PhACs was around 45 μg·L− 1, with the
main contribution of analgesics and anti-inflammatories
(75.0%), followed by psychiatric drugs (15.4%), antihy-
pertensives and other pharmaceuticals. The increase of
analgesics and anti-inflammatories concentration at Day
8 is mainly attributed to the high levels of ketoprofen
and naproxen. Although T. versicolor has proved to
degrade ketoprofen and naproxen both in sterile, defined
media and in non-sterile HWW [8, 13], it was also
hypothesized that it was able to deconjugate conjugated
forms of ketoprofen and naproxen [17, 28, 29]. Briefly,
conjugation is a chemical transformation performed in
the liver in humans used to detoxify xenobiotics. It en-
ables xenobiotics to be more water-soluble and excreted
through urine. These conjugated compounds are present
in the hospital wastewater as a result of human metabol-
ism and can be cleaved by T. versicolor. This could
explain the increase in the concentration of PhACs at
Day 8. This fact established that the PhAC concentration
Fig. 1 Evolution of laccase activity during the continuous treatment. Vertical dotted lines represent the weekly partial biomass regeneration. The
red dashed line represents the average value in a pseudo steady state
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in the influent was equal or higher than at Day 8;
namely, that initial concentrations may be being under-
estimated. In any case the performance is still transitory
because the steady state has not been reached.
From the second week of operation onwards the oper-
ation was considered a pseudo-steady state, given that 5
times the HRT had passed: as can be observed in Fig. 2,
the global pharmaceutical concentration remained con-
stant since Day 15, representing an overall 70% removal.
The treatment is carried out under non-sterile condi-
tions, so from the point of view of other microorgan-
isms, bacteria and fungi different from T. versicolor, it
should not be considered the steady state as a constant
evolution of these populations was revealed through a
DGGE + sequencing approach (section Evolution of bac-
terial and fungal populations in the bioreactor). During
all treatment period, the treatment successfully removed
pharmaceutical active compounds from the real
non-sterile wastewater in a long-term operation. Total
PhAC concentration after treatment was maintained
around 15 μg·L− 1, although groupsdifferent pharmaceut-
ical classes present a variable behaviour. For example:
concentration of analgesics and anti-inflammatories
decreased with time, probably due to an adaptation of
native wastewater analgesics and anti-inflammatories
degraders, as was concluded in a previous study [17]; in
contrast, removal capacity of the psychiatric drugs group
declined. This latter event is further discussed in section
Carbamazepine and venlafaxine removal and transform-
ation products.
Based on the profile of laccase activity and PhAC
removal, it could be concluded that laccase was not
essential to achieve PhAC degradation. Actually,
degradation pathways in WRF are quite diverse: al-
though laccase seems to play an important role in PhAC
degradation [30], cytochrome P450 mechanism has been
pointed out as the main transformation mechanism for
several micropollutants [7, 8]. Therefore, in similar sys-
tems, drop in laccase activity does not necessarily indi-
cate a decrease in PhACs removal efficiency. However,
high concentrations of psychiatric drugs were found by
the end of the treatment, when laccase activity was not
detected. This aspect is further discussed in section
Carbamazepine and venlafaxine removal and transform-
ation products.
The mycelial suspension was prepared by
homogenization of pelleted biomass, as proposed previ-
ously [16], and was used throughout the long-term oper-
ation. This novel method could substantially reduce the
ecological and economic burden of mycelial preparation
an industrial scale, and together with the use of low-cost
medium, the technology could become more attractive
economically.
The average removal of compounds during the steady
state period (from Day 15 onwards) is presented in Fig. 3.
Most analgesics and anti-inflammatories were removed
over 80%, or more if we take into account deconjugation
phenomena because the initial concentration was under-
estimated due to this phenomenon as it was explained
before. Oxycodone was similarly removed (c.a. 60%) in a
previous batch fungal treatment [28], while removal
yield in activated sludge varies between 0 and 50% [31].
Diclofenac, ibuprofen and naproxen, all classified by the
Global Water Research Coalition (GWRC) as high prior-
ity pharmaceuticals [32], were completely removed by
the treatment. Diclofenac, in particular, a widely used
Fig. 2 Concentration profile of pharmaceutically active compounds during the treatment
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anti-inflammatory drug, is usually quite recalcitrant in
WWTPs [3].
Antibiotics were also removed over 80% with the
exception of trimethoprim. Also low removal values for
trimethoprim were achieved in previous studies with
fungi (36–50% [17, 28]) as well as with activated sludge
and even with anaerobic/anoxic/aerobic and UV
processes in WWTPs [31, 33]. The other detected anti-
biotics are usually poorly or not removed in CAS and
membrane bioreactor (MBR) systems [6], so the fungal
treatment emerges as an interesting alternative. In fact,
this long-term treatment slightly improved clarithromy-
cin and sulfamethoxazole removal, but greatly improved
ronidazole removal in comparison with shorter continu-
ous and batch fungal operations (from 0 to 30 to > 90%)
[17, 28].
β-blockers were removed between 50 and > 95%. These
families included atenolol > metoprolol = propranolol >
sotalol, listed in order of priority in GWRC report [32].
Considering that atenolol is the most abundant, the
global β-blockers removal is over 80%. Eleven psychiatric
drugs were detected in the hospital effluent: carba-
mazepine and its 3 TPs and venlafaxine and its 2 TPs
are discussed in detail in section Carbamazepine and
venlafaxine removal and transformation products.
Citalopram was removed around 60% whereas diaze-
pam removal (82%) was much higher than previous
removal efficiencies (0–50%), achieved in shorter-term
operation and batch studies [17, 28]. The removals of
fluoxetine and trazodone were also very high, around
82 and 81%, respectively.
In regards to the miscellaneous group, anthelmintic
levamisole, antiplatelet agent clopidogrel, drug against
prostatic hyperplasia tamsulosin, H1 and H2 receptor
antagonists desloratadine and ranitidine, and lipid regu-
lators atorvastatin, bezafibrate and gemfibrozil were re-
moved around 70% or above, whilst diuretic
hydrochlorothiazide, H1 and H2 receptor antagonist
famotidine and veterinary tranquilizer azaperone were
removed around 50% or below. In general, removal
values for all groups were higher than in previous
short-term studies [17, 28] probably due to the prior
optimization of carbon-to-nitrogen ratio in the nutrients
addition, aeration, biomass renovation and pellet size
[16].
Carbamazepine and venlafaxine removal and
transformation products
Both carbamazepine and venlafaxine are psychiatric
drugs widely used and commonly detected in hospital
wastewater, WWTP influent and also WWTP effluent,
because both compounds are very recalcitrant to bacter-
ial degradation. In fact, carbamazepine and venlafaxine
were, in this order, amongst the most detected
psychiatric drugs in Europe [17, 26, 34, 35]. CBZ is
metabolized in the human liver by a 95% and produces
mainly epoxy-carbamazepine (CBZE), which then is
transformed to acridone; CBZ transformation also pro-
duces 2-hydroxycarbamazepine (2-OH-CBZ), other TPs
and conjugated compounds [36]. These human trans-
formation products can be, and were, detected in the
influent wastewater. Additionally, acridone, CBZE and
Fig. 3 Removal values of pharmaceutically active compounds. Error bars represent the standard deviation of 12 samples during the steady state.
Asterisks mark compounds whose initial concentration contained > 80% of left-censored data
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2-OH-CBZ can also be generated as biodegradation prod-
ucts from fungal and activated sludge activities [7, 37]. Fur-
ther discussion on CBZ degradation pathway on fungi and
humans can be found elsewhere [7]. Carbamazepine (CBZ)
and its TPs 2-OH-CBZ, acridone and CBZE concentration
profiles are presented in Fig. 4a. The long-term operation
removed around 50% of the parent compound CBZ up
until Day 50, when CBZ concentration started to increase
until reaching influent concentration levels. During the
time period where CBZ was biodegraded, 2-OH-CBZ, acri-
done and CBZE were produced by transformation of CBZ,
but the treatment still succeeded in achieving good removal
values of CBZ TPs up to Day 63. By the end of the treat-
ment, though, CBZ TPs were not efficiently removed, even
when no transformation of CBZ was occurring.
Venlafaxine (VEN) is only excreted through the urine by
1–10% unaltered [37]. This means, it is highly metabolized
in humans by cytochrome P450 in liver cells producing pri-
marily O-desmethylvenlafaxine (ODV) –with antidepres-
sant activity– and being N-desmethylvenlafaxine (NDV) a
minor metabolic pathway [38]. Concentration profiles of
venlafaxine and its TPs in the bioreactor are presented in
Fig. 4b. NDV was generally completely removed up to Day
63.
VEN and ODV exhibited low concentrations during
the first 6 weeks of steady state, which after Day 63
slowly rose up to concentrations similar than those in
the influent. It is worth noting that the presence of VEN
in water sample can only be attributed to the input from
influent whereas ODV can be generated from the
Fig. 4 Concentration profile of carbamazepine and its transformation products (a) and venlafaxine and its transformation products (b) during
the treatment
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transformation of VEN. Taking into account both groups
of CBZ + TPs and VEN + TPs, they all followed a similar
pattern, with low concentration at the beginning of the
treatment, followed by an increase from Day 63. This
behavior was similarly described in another fungal oper-
ation (56-day long) where removal of psychiatric drugs
decreased over time; it was attributed to an inhibition by
Candida [17]. In this case, as CBZ and CBZE can be
removed by both laccase and the intracellular cyto-
chrome P450 [39, 40], the decrease in laccase activity
might have affected CBZ removal. Additionally, a syner-
gistic effect was hypothesized between fungal and
bacterial enzymes that led to a high removal of VEN in a
batch treatment [12]. An increase in CBZ and its TPs
degradation was also observed when non-sterile
wastewater was treated, in contrast to sterile WW.
Therefore, the microbial community might have played
a role in the psychiatric drugs removal diminution (fur-
ther discussed in section Evolution of bacterial and fun-
gal populations in the bioreactor).
Evolution of bacterial and fungal populations in the
bioreactor
The evolution of microbial populations in the liquid
matrix was assessed using DGGE and sequencing of
prominent bands, while tracking of Trametes versicolor
in the pellet and liquid matrices was performed by
real-time qPCR. DGGE gels are presented in Additional
file 1: Figures S2 and S3. A total of 45 bands were recov-
ered from bacteria and 33 bands from fungi, represent-
ing 90 and 98% coverage in the quantitative DGGE band
matrix, respectively. Unidentified bands were not consid-
ered in further analyses.
Bacterial sequences belonged to 12 different genera
(Acinetobacter, Acutalibacter, Azospirillum, Comamonas,
Delftia, Faecalibacterium, Flavobacterium, Luteibacter,
Ochrobactrum, Pandoraea, Raoultella and Stenotropho-
monas) from the Bacteroidetes, Firmicutes and Proteobac-
teria phyla. Results displaying the relative abundances of
phyla (or classes, in the case of proteobacteria) are pre-
sented in Fig. 5. On one hand, Gammaproteobacteria were
Fig. 5 Phylogenetic assignment of bacterial (a) and fungal (b) sequences from the liquid matrix of the bioreactor. Data is presented in form of
relative abundance, previously calculated using the semi-quantitative DGGE matrix and the sequenced bands from DGGE gels. Unidentified bands
(10% for bacteria and 2% for fungi) were not represented
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abundant in the early operation of the bioreactor but os-
cillated along time displaying three peaks at days 15, 43
and 78. Bacteroidetes behaved similarly, although with
lower relative abundances. On the other hand, the Beta-
proteobacteria was the only group present during all the
operation, with particularly high relative abundances
(from 0.18 to 1) throughout the mid-late period. This bac-
terial taxon showed to be well adapted to fungal treatment
in a previous work [17]. Firmicutes were only found at the
influent and did not colonize the reactor.
Half of the genera (Acinetobacter, Comamonas, Delftia,
Flavobacterium, Ochrobactrum and Stenotrophomonas)
detected in this study have been found in activated
sludge treatments [41, 42]. In fact, both Comamonas
and Pandoraea seemed to be involved in the removal
processes, as their abundance during this and previous
operations [17] exhibited significative correlations with
either psychiatric drugs or antibiotics removal. In the
first case, Comamonas was negatively correlated to psy-
chiatric drug removal (r = − 0.53 p < 0.01). Basically, the
genus was abundant when none or low psychiatric drug
removal was observed. In the second case, Pandoraea
had a strong positive correlation with antibiotics re-
moval (r = 0.60 p < 0.01). Bacteria from genus Pandoraea
are known for their metabolic versatility; some strains
are capable of organohalogenate, PAH degradation [43,
44]. While some species are usually found in soil, the
genus was described in 2000 [45] from patients suffering
cystic fibrosis and it is precisely in the clinical field that
many species have been characterized for multiple anti-
biotic resistance. Antibiotic susceptibility tests revealed
resistance of Pandoraea isolates to beta-lactams,
ciprofloxacin, and even colistin, a last resort antibiotic
[45, 46]. While more studies would be necessary to as-
sess to which degree Pandoraea is involved in antibiotic
degradation, its ability to thrive in presence of antibiotics
surely provides fitness advantages in front of other spe-
cies. By counterpart, the appearance of this genus drew
attention to the authors regarding the possibility of
pathogenic species being enriched in the liquid matrix
and the need to develop further strategies to prevent it.
As a whole, the acidic pH of the reactor, the HRT of 3
days and the presence of T. versicolor and its enzymes
and microbial products might have affected the bacterial
composition developing in the bioreactor. The loss of
psychiatric drugs removal from Day 57 onwards could
be attributed to the bacterial shift that led to a major
abundance of Betaproteobacteria over the other groups.
Even if there was no degradation of psychiatric drugs by
bacteria in an earlier period, they may have played a role
in the further degradation of fungal metabolites, thereby
allowing an increased reactor removal capacity [47].
In regards to fungal populations (Fig. 5), although
many fungi are typically present in wastewater [48], the
semi-quantitative approach DGGE + sequencing identified
three fungal genera in the liquid fraction of the bioreactor:
Clitopilus (Basidiomycota) Trametes (Basidiomycota) and
Fusarium (Ascomycota). Additionally, to further under-
stand the system, the concentration of Trametes versicolor
in the pellets and liquid matrix was determined through
the quantitative, more sensible approach of real-time
qPCR. T. versicolor ITS copies per mg of pellet and per
mL of HWW are presented in Fig. 6a and b, respectively.
Clitopilus was only found at the beginning and did not
colonize the liquid fraction of the reactor at the condi-
tions of operation. Contrarily, Fusarium rapidly colo-
nized the liquid fraction up to a relative abundance of
≥0.92 until Day 43, when the concentration of Trametes
in the liquid steadily rose from 106 to 109 ITS copies ·
mL− 1 due to the breakdown of pellets into free, dis-
solved mycelium (Fig. 6). A sporadic increase in turbid-
ity and appearance of pink pigmentation was observed
between days 33 and 37, corresponding with the appear-
ance and increase in abundance of the Gammaproteo-
bacteria Luteibacter. Recent studies reported the
appearance of pink-hued contaminant strains belonging
to this genus [49]. Interestingly, this event occurred dur-
ing the same period when Trametes overtook the dom-
inance of the bioreactor. Although the same pigmented
bacterium might have antagonistically interacted with
Fusarium, ITS copies of Trametes versicolor in the liquid
matrix were increasing since day 0. The biomass renova-
tion of Day 37 helped in outcompeting Fusarium for the
rest of the operation, observed in the DGGE with rela-
tive abundances ranging between 0.75–0.95 and con-
firmed with the qPCR, with a steady concentration
between 9 × 107 and 2 × 109 mL HWW− 1. Weekly partial
biomass renovations were most likely a major contribu-
tor to the predominance of T. versicolor throughout the
operation. Fusarium is a genus of filamentous fungi
which includes plant pathogens, but has been studied
for dye and steroid degradation [50, 51]. Therefore, its
ability and role in the removal of PhACs during the op-
eration could not be disregarded. T. versicolor concen-
tration in the pellets (Fig. 6) was maintained since day
29 around 109 ITS copies per mg of pellet. In fact, it
seemed that the partial biomass restoration strategy pro-
duced a balance between Trametes in the form of free
mycelium (109 ITS copies · mL-1) and in the shape of
pellet (109 ITS copies mg pellet− 1) after Day 36.
Finally, to our knowledge this is the first time that the
operation has been kept for such a long time. Indeed, a
long-term fungal operation to treat non-sterile hospital
wastewater (with high loads of PhACs) has been demon-
strated for the first time. The fungal approach allowed
the removal of the vast majority of compounds from the
wastewater during a period of 91 days. The fungal re-
moval capability for most compounds was confirmed
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despite of the presence of native wastewater microorgan-
isms. The treatment significantly reduced the pharma-
ceutical load of 4 PhACs listed in the initial watch list of
the EU Commission (carbamazepine, clarithromycin,
ibuprofen and sulfamethoxazole) [52], and 18 com-
pounds listed in the priority list of the Global Water Re-
search Coalition [32]. Average removal of PhACs was
around 80%, with the exception of carbamazepine, beza-
fibrate, hydrochlorothiazide, metoprolol and trimetho-
prim (around 50% removal). Increasing the HRT or the
fungal concentration could help in improving the re-
moval of pharmaceuticals.
Conclusions
A long term of fungal treatment removing PhACs from
real hospital wastewater has been demonstrated for the
first time. The fungus confirmed the ability of bioreme-
diating most compounds from this heavily contaminated
matrix. With the suitable strategic conditions is possible
to maintain the fungal activity for 90 days. Furthermore,
Fig. 6 Real-time qPCR quantification of Trametes versicolor ITS copies during the bioreactor operation in the pellets (a) and liquid matrix (b).
Standard deviation of qPCR reaction triplicates is included. Liquid matrix sample from day 0 did not amplify
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the balance between Trametes as a pellet and free myce-
lium was observed by qPCR. A negative interaction
between Gammaproteobacteria Luteibacter and WRF T.
versicolor was described for the first time, although no
effect on laccase production or removal efficiency was
noted. At the same time Pandoraea was identified as a
putative antibiotic remover.
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